PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-08-02

Date Title Company
02-Aug-2021 Gas Equipment Market Size Share, Global Industry Brief Analysis by Trend, Growth, Competition, Demand, SWOT Analysis, COVID-19 Impact Analysis The Wire Times
02-Aug-2021 Patient Handling Equipment Market Size, Demand, Growth, COVID 19 Impact Analysis, Share, Revenue and Forecast 2026 The Wire Times
02-Aug-2021 Health Canada Grants No Objection Letter to Epygenix Therapeutics to Proceed With ARGUS Trial for the Treatment of Dravet Syndrome Newswire
02-Aug-2021 Skin Tightening Market Growth, Size, Analysis, Outlook by 2021 – Trends, Opportunities and Forecast to 2028 – Hologic, Inc Cutera Venus Concept ALLERGAN Alma Lasers The Wire Times
02-Aug-2021 Particle Therapy Market 2021 | Outlook, Growth By Top Companies, Regions, Types, Applications, Drivers, Trends & Forecasts by 2028 The Wire Times
02-Aug-2021 North America Neuroendocrine Tumors Market Outlook, Strategies, Manufacturers, Countries, Type and Application, Global Forecast To 2028 The Wire Times
02-Aug-2021 North America Active Pharmaceutical Ingredients (API) Market Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics & Forecast to 2028 The Wire Times
02-Aug-2021 North America Psychedelic Drugs Market 2021 | Outlook, Growth By Top Companies, Regions, Types, Applications, Drivers, Trends & Forecasts by 2028 The Wire Times
02-Aug-2021 Epygenix Therapeutics Receives U.S. FDA Orphan Drug Designation for EPX-200 in Lennox-Gastaut Syndrome Newswire
02-Aug-2021 Middle East and Africa Invisible Orthodontics Market: Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2028 The Wire Times
02-Aug-2021 North America Digital Therapeutic (DTx) Market is Expected to Reach USD 10,639.36 Million & Advanced Tech & Growth Opportunities In Global Industry By 2028 The Wire Times
02-Aug-2021 Epygenix Therapeutics Receives Orphan Medicinal Product Designation in Europe With EPX-200 for the Treatment of Patients With Dravet Syndrome Newswire